The $1,000 genome has been a catchphrase of the sequencing industry for years, but despite bold promises from different companies, this benchmark hasn’t been met. Now, thanks to a new sequencing machine from Illumina, it may finally be within reach.
At the J.P. Morgan Healthcare Conference on Tuesday, Illumina CEO Jay Flatley announced a new high-end sequencing machine that could accurately sequence whole human genomes at a cost of less than $1,000 each.
The $1,000 price tag is often seen as vital to making whole-genome sequencing cost-effective for medical testing and personalized medicine. At this price, it might become reasonable for well-off patients to have their genomes sequenced for potential medical information.
Read the full, original story: Does Illumina Have the First $1,000 Genome?
- Not Quite the $1,000 Genome, But Maybe Close Enough, Forbes
- These Machines Just Broke the Sound Barrier of Human Genome Sequencing, Gizmodo
- The $1,000 Genome Is Almost Here-–Are We Ready?, Scientific American